Cipher Pharmaceuticals Inc.

TSX:CPH.TO

15.55 (CAD) • At close October 30, 2024
Bedrijfsnaam Cipher Pharmaceuticals Inc.
Symbool CPH.TO
Munteenheid CAD
Prijs 15.55
Beurswaarde 397,907,395
Dividendpercentage 0%
52-weken bereik 4.3 - 19.69
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Craig J. Mull
Website https://www.cipherpharma.com

An error occurred while fetching data.

Over Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Its commercial products include Epuris (CIP-ISOTRETINOIN), a formulation of the active ingredient isotretinoin for use in the treatment of severe acne; Ozenoxacin to treat adult and paediatric patients with impetigo; Actikerall, which is indicated for the treatment of palpable

Vergelijkbare Aandelen

Titan Medical Inc. logo

Titan Medical Inc.

TMD.TO

1.125 CAD

Avant Brands Inc. logo

Avant Brands Inc.

AVNT.TO

0.155 CAD

Resverlogix Corp. logo

Resverlogix Corp.

RVX.TO

0.065 CAD

Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp.

MDNA.TO

0.36 CAD

Spectral Medical Inc. logo

Spectral Medical Inc.

EDT.TO

0.6 CAD

Microbix Biosystems Inc. logo

Microbix Biosystems Inc.

MBX.TO

0.315 CAD

Oncolytics Biotech Inc. logo

Oncolytics Biotech Inc.

ONC.TO

2.12 CAD

Financiële Gegevens

Cijfers zijn in miljoenen (CAD)

Cijfers zijn in miljoenen (CAD)